ImmuCell Corp (NASDAQ:ICCC)

4.52
Delayed Data
As of Nov 30
 0.00 / 0.00%
Today’s Change
4.26
Today|||52-Week Range
7.84
-25.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues3.0M2.2M2.9M4.4M
 
 
 
 
 
Cost of Goods Sold1.2M820.2K973.0K2.0M
 
 
 
 
 
Depreciation And Amortization285.5K382.6K568.0K568.6K
 
 
 
 
 
 
Operating ExpensesGross Income1.5M951.0K1.4M1.8M
 
 
 
 
 
General Expenses1.7M1.8M2.3M1.5M
 
 
 
 
 
Research And Development761.9K908.8K1.3M536.4K
 
 
 
 
 
Total Operating Expenses3.2M3.0M3.9M4.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-193.4K-849.1K-926.0K265.3K
 
 
 
 
 
Interest Expense On Debt106.3K109.7K115.8K114.0K
 
 
 
 
 
Other Expenses-70.00700.0K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-296.5K-255.6K-1.0M153.6K
 
 
 
 
 
Income Taxes-501.8K-5.6K-14.0K-9.0K
 
 
 
 
 
Net Income-798.4K-250.0K-1.1M144.6K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.5M5.5M5.5M5.6M
 
 
 
 
 
Shares To Calculate EPS Diluted5.5M5.5M5.5M5.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.05-$0.19$0.03
 
 
 
 
 
EPS Diluted-$0.15-$0.05-$0.19$0.03